# James Fickel

> James Fickel is a seed investor at Starbloom Capital backing Solar and Energy. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Starbloom Capital](https://shizune.co/investors/profile/starbloom-capital)
- Total investments: 5
- Last investment: Nov 2025
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/james-fickel-4a971169

James Fickel is a seed investor at Starbloom Capital focused on Solar and Energy. James Fickel

## Contacts

5 contacts available for James Fickel: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/james-fickel-9af8?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.5M–$8.2M |
| Series A | $13M–$27M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Solar | 1 | 20% |
| Energy | 1 | 20% |
| Medical | 1 | 20% |
| Oncology | 1 | 20% |
| Biopharma | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series A | 2 | 40% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| United Kingdom | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| 0xbow | 0xbow is an Ethereum privacy service provider that primarily offers support for Sky’s USDS stablecoin, delivering secure, confidential, and user-friendly transaction solutions within the decentralized finance ecosystem. | $3.5M | Seed | Nov 18, 2025 |  |
| LIfT BioSciences | LIfT Biosciences is a biotech company that develops allogeneic cell therapies using Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic or induced pluripotent stem cells. The company leverages its patented N‑LIfT platform to generate neutrophils capable of directly destroying cancer cells and reprogramming the tumormicroenvironment to enhance immune recruitment. Preclinical data have shown potent activity across multiple solid tumor types, with Phase I clinical trials in metastatic cervical and head‑and‑neck cancer planned in partnership with the University of Galway. | $13.4M | Series A | Sep 24, 2024 |  |
| Swift Solar | Swift Solar is a company focused on developing advanced solar technology. The company's core innovation is perovskite solar cells, designed to be more efficient and affordable than traditional solar panels. Swift Solar emphasizes domestic manufacturing and abundant raw materials to ensure scalability. | $27M | Series A | Jun 12, 2024 |  |
| LIfT BioSciences | LIfT Biosciences is a biotech company that develops allogeneic cell therapies using Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic or induced pluripotent stem cells. The company leverages its patented N‑LIfT platform to generate neutrophils capable of directly destroying cancer cells and reprogramming the tumormicroenvironment to enhance immune recruitment. Preclinical data have shown potent activity across multiple solid tumor types, with Phase I clinical trials in metastatic cervical and head‑and‑neck cancer planned in partnership with the University of Galway. | $7M | Venture - Series Unknown | Dec 19, 2022 |  |
| Swift Solar | Swift Solar is a company focused on developing advanced solar technology. The company's core innovation is perovskite solar cells, designed to be more efficient and affordable than traditional solar panels. Swift Solar emphasizes domestic manufacturing and abundant raw materials to ensure scalability. | $8.2M | Seed | Dec 14, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Climate Capital](https://shizune.co/investors/profile/climate-capital) — VC Fund, 2 deals together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 2 deals together
- [BlueScopeX](https://shizune.co/investors/profile/bluescopex) — VC Fund, 1 deal together
- [Boost VC](https://shizune.co/investors/profile/boostfunder) — VC Fund, 1 deal together
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund, 1 deal together
- [Eni Next](https://shizune.co/investors/profile/eni-next) — VC Fund, 1 deal together

## About Starbloom Capital

VC Fund

Starbloom Capital is an investment firm.

1 contacts available at Starbloom Capital.

| Name | Title | Profile |
| --- | --- | --- |
| James Fickel | Investor | https://shizune.co/investors/profile/james-fickel-9af8 |

## Similar investors

### Similar industry
- [Lowercarbon Capital](https://shizune.co/investors/profile/lowercarbon-capital) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Renewable Energy Angel Investors in United States](https://shizune.co/investors/renewable-energy-angel-investors-united-states)

## FAQ

### What does James Fickel invest in?

James Fickel invests primarily in Solar, Energy and Medical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is James Fickel's check size?

James Fickel typically joins rounds of $3.5M–$8.2M at Seed and $13M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds James Fickel participates in.

### How do I contact James Fickel?

Public channels for James Fickel include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did James Fickel last invest?

The most recent investment recorded for James Fickel closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co